IBS vs IBD differences

IBS (Irritable Bowel Syndrome) is a functional disorder, meaning the bowel does not work as it should but there is no visible damage or inflammation. IBD (Inflammatory Bowel Disease, including Crohn's disease and ulcerative colitis) involves actual inflammation and damage to the bowel wall, which can be seen on scans or colonoscopy. This distinction affects how each is diagnosed and treated.

IBS is usually diagnosed based on symptom patterns after ruling out other causes, often without needing invasive testing if there are no red-flag features. IBD diagnosis typically requires colonoscopy, biopsies, and sometimes imaging or blood tests to confirm inflammation and identify its extent. Blood or stool markers like calprotectin can help distinguish between the two before more invasive testing.

There is significant overlap, with both causing abdominal pain, bloating, and changes in bowel habit, which is why they can be confused initially. IBD more often involves additional features such as rectal bleeding, unintended weight loss, fever, or symptoms that wake you at night. Any of these additional features should prompt further investigation rather than assuming IBS.

IBD is generally considered more serious because ongoing inflammation can lead to complications such as strictures, fistulas, or an increased long-term risk of bowel cancer if not well controlled. IBS, while it can significantly affect quality of life, does not cause this kind of structural damage. Both, however, deserve proper diagnosis and management to protect your wellbeing.

Yes, it is possible to have IBD that is well controlled from an inflammation standpoint but still experience IBS-type symptoms such as ongoing bloating or altered bowel habit. This is sometimes called "IBS-like symptoms in IBD" and can make symptom management more complex. Your gastroenterologist can help work out which symptoms relate to which condition.

IBD does have a stronger recognised genetic and family component than IBS, though environmental factors also play a significant role in both conditions. Having a close relative with IBD modestly increases your own risk, whereas the genetic link in IBS is less clearly established. Neither guarantees you will develop the condition even with a family history.

IBS treatment generally focuses on diet, lifestyle changes, and medications to manage symptoms like pain or altered bowel habit. IBD treatment aims to reduce and control inflammation directly, often using anti-inflammatory medications, immunosuppressants, or biologic drugs, and sometimes surgery in more severe cases. The underlying goals of treatment are quite different because one is symptom-focused and the other disease-focused.

A faecal calprotectin test, which detects inflammation markers in stool, is commonly used as a first step to help distinguish between the two before considering a colonoscopy. Blood tests looking for markers of inflammation or anaemia can also provide clues. If results suggest inflammation, a colonoscopy is usually the next step to confirm an IBD diagnosis.

IBS is not considered a risk factor for developing IBD, and the two are understood to have different underlying mechanisms. However, because symptoms can overlap, it is important that new or worsening symptoms are reassessed rather than automatically attributed to a previous IBS diagnosis. If in doubt, it is always worth getting new red-flag symptoms checked.

See a doctor promptly if you have rectal bleeding, unexplained weight loss, fever, or bowel symptoms that wake you at night, as these need to be checked for IBD or other causes. NHS gastroenterology referrals can take 20-45+ weeks routinely, while private consultants can often see you within about 2 weeks. Getting an early, accurate diagnosis helps make sure you get the right treatment for the right condition.